MGEN - miRagen Therapeutics' (MGEN) CEO Bill Marshall on Q3 2019 Results - Earnings Call Transcript
miRagen Therapeutics, Inc. (MGEN)
Q3 2019 Earnings Conference Call
November 7, 2019 4:30 PM ET
Company Participants
Dan Ferry – Managing Director of LifeSci Advisors
Bill Marshall – President and Chief Executive Officer
Jason Leverone – Chief Financial Officer
Conference Call Participants
Jonathan Miller – Evercore ISI
Leland Gershell – Oppenheimer
Madhu Kumar – R.W. Baird
Liana Moussatos – Wedbush Securities
Presentation
Operator
Thank you for standing by. This is the conference operator. Welcome to the miRagen Therapeutics Third Quarter 2019 Earnings Conference Call. [Operator Instructions] And the conference is being recorded. [Operator Instructions] I